Samir Mitragotri, PhD, is a professor of bioengineering at Harvard University and the founder of CAGE Bio
CAGE Bio Advances Skin Disease Treatment
Mitragotri's work bridges advanced drug development and skin care for tailored treatments.
Bridging Therapeutic Innovation and Dermatology
Advancements in therapeutic agents demand innovative strategies for safe, localized skin treatments, Mitragotri argues.
Next-Gen Therapy: Advancing Topical Therapeutics
Mitragotri said new innovations like ionic liquid-based delivery systems can offer better treatment for immunodermatological conditions.
Ionic Liquids Boost Skin Drug Delivery
The innovative technology is unlocking new possibilities in dermatology by improving the solubility and permeability of drugs for topical use.
Daily Derm Times: April 15, 2025
Compound Heparin Sodium Allantoin Gel Can Treat Rosacea and Improve Skin Barrier
New Study Sheds Light on Vitiligo-CHD Association
Topical Antioxidants Combined with Phototherapy Effective for Vitiligo Management